VanEck Pharmaceutical ETF (PPH)

Nasdaq
$114.85-0.09%As of 2026-11-22 · USD
Last session low $114.56Last session high $116.93
52-week low $97.5252-week high $124.17
P/E (TTM)
26.8x
Dividend yield
1.79%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-19 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)42.6In the neutral range (30 to 70)
MACD (12, 26, 9)1.35Below its signal line (2.00); histogram -0.65
Bollinger %B (20, 2)15%Inside the bands (113.24 to 124.31)
SMA 20118.78Price is 3.3% below
SMA 50114.25Price is 0.5% above
SMA 200108.41Price is 5.9% above
ATR (20)1.96% of priceAverage true range per day
52-week position65%In the middle of the 97.52 to 124.17 range

About VanEck Pharmaceutical ETF

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

More Health ETFs